{ "x402Version": 2, "id": 39589, "slug": "39589", "resource": "https://api.magentlab.com/api/calc/hfa_icos_vegf", "description": "Lyon 2020 HFA-ICOS baseline CV risk before VEGF inhibitors or VEGF TKIs. Very high if heart failure/cardiomyopathy or arterial vascular disease. High if venous thrombosis, LVEF <50%, QTc >=480 ms, age >=75, hypertension, prior anthracycline, or >=5 medium points. Medium if 2-4 medium points. Guide <2% / 2-9% / 10-19% / >=20%. Not a device or treatment order.", "type": "http", "serviceName": "magent", "resourceType": "Agent Service", "accepts": [ { "scheme": "exact", "network": "eip155:8453", "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2", "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913", "amount": "5000", "amountUsd": 0.005, "maxTimeoutSeconds": 600 } ], "outputSchema": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" }, "extensions": { "bazaar": { "info": { "iconUrl": "https://api.magentlab.com/favicon.ico", "input": { "body": { "items": [ { "age_years": 50, "arrhythmia": false, "arterial_vascular_disease": false, "ckd": false, "current_or_significant_smoker": false, "diabetes": false, "elevated_bnp": false, "elevated_troponin": false, "heart_failure_or_cardiomyopathy": false, "hyperlipidemia": false, "hypertension": false, "lvef_percent": 60, "obesity": false, "prior_anthracycline": false, "prior_left_chest_or_mediastinal_rt": false, "proteinuria": false, "qtc_ms": 400, "sex": "female", "venous_thrombosis": false }, { "age_years": 50, "arrhythmia": false, "arterial_vascular_disease": false, "ckd": false, "current_or_significant_smoker": false, "diabetes": false, "elevated_bnp": false, "elevated_troponin": false, "heart_failure_or_cardiomyopathy": false, "hyperlipidemia": false, "hypertension": false, "lvef_percent": 60, "obesity": false, "prior_anthracycline": false, "prior_left_chest_or_mediastinal_rt": false, "proteinuria": false, "qtc_ms": 400, "sex": "female", "venous_thrombosis": false } ] }, "method": "POST", "type": "http" }, "output": { "example": { "count": 2, "items": [ { "age_years": 50, "cardiotoxicity_guide": "<2%", "citation": { "authors": "Lyon AR, Dent S, Stanway S, et al.", "doi": "10.1002/ejhf.1920", "id": "lyon-2020", "pmid": "32458582", "source": "Eur J Heart Fail. 2020;22(11):1945-1960", "title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society" }, "components": [ { "factor": "heart_failure_or_cardiomyopathy", "points": 0, "present": false, "tier": "very_high" }, { "factor": "arterial_vascular_disease", "points": 0, "present": false, "tier": "very_high" }, { "factor": "venous_thrombosis", "points": 0, "present": false, "tier": "high" }, { "factor": "lvef_lt_50", "points": 0, "present": false, "tier": "high" }, { "factor": "qtc_ge_480", "points": 0, "present": false, "tier": "high" }, { "factor": "age_ge_75", "points": 0, "present": false, "tier": "high" }, { "factor": "hypertension", "points": 0, "present": false, "tier": "high" }, { "factor": "prior_anthracycline", "points": 0, "present": false, "tier": "high" }, { "factor": "lvef_50_to_54", "points": 0, "present": false, "tier": "medium_2" }, { "factor": "borderline_qtc", "points": 0, "present": false, "tier": "medium_2" }, { "factor": "arrhythmia", "points": 0, "present": false, "tier": "medium_2" }, { "factor": "elevated_troponin", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "elevated_bnp", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "age_65_to_74", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "diabetes", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "hyperlipidemia", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "ckd", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "proteinuria", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "prior_left_chest_or_mediastinal_rt", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "current_or_significant_smoker", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "obesity", "points": 0, "present": false, "tier": "medium_1" } ], "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "hfa_icos_vegf", "formula_expression": "HFA-ICOS VEGF-inhibitor class (Lyon 2020): very_high if any very-high factor; else high if any high factor or medium_points>=5; else medium if medium_points 2-4; else low. medium_points = Medium 2 + Medium 1 only. Very high: heart_failure_or_cardiomyopathy, arterial_vascular_disease (IHD, PCI, CABG, stable angina, TIA, stroke, or PVD). High: venous_thrombosis, lvef_percent<50, qtc_ms>=480, age_years>=75, hypertension, prior_anthracycline. Medium 2: lvef 50-54, male 450<=qtc<480, female 460<=qtc<480, arrhythmia (AF/flutter/VT/VF). Medium 1: elevated_troponin, elevated_bnp, age 65-74, diabetes, hyperlipidemia, ckd, proteinuria, prior_left_chest_or_mediastinal_rt, current_or_significant_smoker, obesity. Age exclusive (>=75 High; 65-74 Medium 1; <65 none). LVEF exclusive (<50 High; 50-54 Medium 2; >=55 none). QTc exclusive (>=480 High; else sex-specific Medium 2). cardiotoxicity_guide low <2%, medium 2-9%, high 10-19%, very_high >=20%", "high_factor": false, "lvef_percent": 60, "medium_points": 0, "qtc_ms": 400, "risk_level": "low", "sex": "female", "very_high_factor": false }, { "age_years": 50, "cardiotoxicity_guide": "<2%", "citation": { "authors": "Lyon AR, Dent S, Stanway S, et al.", "doi": "10.1002/ejhf.1920", "id": "lyon-2020", "pmid": "32458582", "source": "Eur J Heart Fail. 2020;22(11):1945-1960", "title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society" }, "components": [ { "factor": "heart_failure_or_cardiomyopathy", "points": 0, "present": false, "tier": "very_high" }, { "factor": "arterial_vascular_disease", "points": 0, "present": false, "tier": "very_high" }, { "factor": "venous_thrombosis", "points": 0, "present": false, "tier": "high" }, { "factor": "lvef_lt_50", "points": 0, "present": false, "tier": "high" }, { "factor": "qtc_ge_480", "points": 0, "present": false, "tier": "high" }, { "factor": "age_ge_75", "points": 0, "present": false, "tier": "high" }, { "factor": "hypertension", "points": 0, "present": false, "tier": "high" }, { "factor": "prior_anthracycline", "points": 0, "present": false, "tier": "high" }, { "factor": "lvef_50_to_54", "points": 0, "present": false, "tier": "medium_2" }, { "factor": "borderline_qtc", "points": 0, "present": false, "tier": "medium_2" }, { "factor": "arrhythmia", "points": 0, "present": false, "tier": "medium_2" }, { "factor": "elevated_troponin", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "elevated_bnp", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "age_65_to_74", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "diabetes", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "hyperlipidemia", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "ckd", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "proteinuria", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "prior_left_chest_or_mediastinal_rt", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "current_or_significant_smoker", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "obesity", "points": 0, "present": false, "tier": "medium_1" } ], "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "hfa_icos_vegf", "formula_expression": "HFA-ICOS VEGF-inhibitor class (Lyon 2020): very_high if any very-high factor; else high if any high factor or medium_points>=5; else medium if medium_points 2-4; else low. medium_points = Medium 2 + Medium 1 only. Very high: heart_failure_or_cardiomyopathy, arterial_vascular_disease (IHD, PCI, CABG, stable angina, TIA, stroke, or PVD). High: venous_thrombosis, lvef_percent<50, qtc_ms>=480, age_years>=75, hypertension, prior_anthracycline. Medium 2: lvef 50-54, male 450<=qtc<480, female 460<=qtc<480, arrhythmia (AF/flutter/VT/VF). Medium 1: elevated_troponin, elevated_bnp, age 65-74, diabetes, hyperlipidemia, ckd, proteinuria, prior_left_chest_or_mediastinal_rt, current_or_significant_smoker, obesity. Age exclusive (>=75 High; 65-74 Medium 1; <65 none). LVEF exclusive (<50 High; 50-54 Medium 2; >=55 none). QTc exclusive (>=480 High; else sex-specific Medium 2). cardiotoxicity_guide low <2%, medium 2-9%, high 10-19%, very_high >=20%", "high_factor": false, "lvef_percent": 60, "medium_points": 0, "qtc_ms": 400, "risk_level": "low", "sex": "female", "very_high_factor": false } ], "path": "/api/calc/hfa_icos_vegf" }, "type": "json" } }, "schema": { "$schema": "https://json-schema.org/draft/2020-12/schema", "properties": { "input": { "additionalProperties": false, "properties": { "body": { "additionalProperties": false, "properties": { "items": { "items": { "properties": { "age_years": { "description": "Integer age in years (18-100) as assigned by the caller. Lyon 2020 VEGF-inhibitor table: >=75 High; 65-74 Medium 1; <65 no age points. Bands are exclusive. magent does not read an identity document.", "type": "integer" }, "arrhythmia": { "description": "Arrhythmia (atrial fibrillation, atrial flutter, ventricular tachycardia, or ventricular fibrillation) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 2). true or false.", "type": "boolean" }, "arterial_vascular_disease": { "description": "Arterial vascular disease: IHD, PCI, CABG, stable angina, TIA, stroke, or PVD as one caller bool (Lyon 2020 VEGF-inhibitor table, very high). true or false. magent does not diagnose vascular disease.", "type": "boolean" }, "ckd": { "description": "Chronic kidney disease (eGFR <60 mL/min/1.73 m2) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not compute eGFR.", "type": "boolean" }, "current_or_significant_smoker": { "description": "Current smoker or significant smoking history as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.", "type": "boolean" }, "diabetes": { "description": "Diabetes mellitus (glycated haemoglobin >7.0% or >53 mmol/mol, or on treatment) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.", "type": "boolean" }, "elevated_bnp": { "description": "Elevated baseline BNP or NT-proBNP above the local laboratory upper limit of normal as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not assay BNP.", "type": "boolean" }, "elevated_troponin": { "description": "Elevated baseline troponin above the local laboratory upper limit of normal as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not assay troponin.", "type": "boolean" }, "heart_failure_or_cardiomyopathy": { "description": "Heart failure or cardiomyopathy (Lyon 2020 VEGF-inhibitor table, very high). Caller-assigned. true or false.", "type": "boolean" }, "hyperlipidemia": { "description": "Hyperlipidemia (non-HDL cholesterol >3.8 mmol/L or >145 mg/dL) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not convert lipid units.", "type": "boolean" }, "hypertension": { "description": "Hypertension (SBP >140 mmHg or DBP >90 mmHg, or on treatment) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, High). true or false. magent does not read a blood-pressure cuff.", "type": "boolean" }, "lvef_percent": { "description": "Baseline left-ventricular ejection fraction, integer percent 10-80, as assigned by the caller. <50 High; 50-54 Medium 2; >=55 no LVEF points. magent does not read an echocardiogram.", "type": "integer" }, "obesity": { "description": "Obesity (BMI >30 kg/m2) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not compute BMI.", "type": "boolean" }, "prior_anthracycline": { "description": "Prior anthracycline exposure as assigned by the caller (Lyon 2020 VEGF-inhibitor table, High). true or false.", "type": "boolean" }, "prior_left_chest_or_mediastinal_rt": { "description": "Prior radiotherapy to the left chest or mediastinum as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.", "type": "boolean" }, "proteinuria": { "description": "Proteinuria as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.", "type": "boolean" }, "qtc_ms": { "description": "Baseline QTc in milliseconds, integer 300-700, as assigned by the caller. >=480 High; men 450-479 Medium 2; women 460-479 Medium 2. magent does not measure QTc.", "type": "integer" }, "sex": { "description": "male or female as assigned by the caller. Used only for the sex-specific borderline QTc Medium 2 band (men 450-479 ms; women 460-479 ms).", "type": "string" }, "venous_thrombosis": { "description": "Venous thrombosis (DVT or PE) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, High). true or false.", "type": "boolean" } }, "required": [ "age_years", "sex", "lvef_percent", "qtc_ms", "heart_failure_or_cardiomyopathy", "arterial_vascular_disease", "venous_thrombosis", "hypertension", "prior_anthracycline", "arrhythmia", "elevated_troponin", "elevated_bnp", "diabetes", "hyperlipidemia", "ckd", "proteinuria", "prior_left_chest_or_mediastinal_rt", "current_or_significant_smoker", "obesity" ], "type": "object" }, "maxItems": 25, "minItems": 1, "type": "array" } }, "required": [ "items" ], "type": "object" }, "headers": { "additionalProperties": { "type": "string" }, "type": "object" }, "method": { "const": "POST", "type": "string" }, "type": { "const": "http", "type": "string" } }, "required": [ "type", "method" ], "type": "object" }, "output": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" } }, "required": [ "input" ], "type": "object" } } }, "tags": [ "hfa-icos", "vegf-inhibitor", "cardio-oncology", "lyon-2020", "calculator", "bazaar" ], "sourceHost": "api.magentlab.com", "lastUpdated": "2026-10-12T13:35:26.251Z", "quality": { "calls30d": 3, "uniquePayers30d": 1, "lastCalledAt": "2026-10-12T13:35:26.104Z" }, "metadata": { "serviceName": "magent", "extensions": { "bazaar": { "info": { "iconUrl": "https://api.magentlab.com/favicon.ico", "input": { "body": { "items": [ { "age_years": 50, "arrhythmia": false, "arterial_vascular_disease": false, "ckd": false, "current_or_significant_smoker": false, "diabetes": false, "elevated_bnp": false, "elevated_troponin": false, "heart_failure_or_cardiomyopathy": false, "hyperlipidemia": false, "hypertension": false, "lvef_percent": 60, "obesity": false, "prior_anthracycline": false, "prior_left_chest_or_mediastinal_rt": false, "proteinuria": false, "qtc_ms": 400, "sex": "female", "venous_thrombosis": false }, { "age_years": 50, "arrhythmia": false, "arterial_vascular_disease": false, "ckd": false, "current_or_significant_smoker": false, "diabetes": false, "elevated_bnp": false, "elevated_troponin": false, "heart_failure_or_cardiomyopathy": false, "hyperlipidemia": false, "hypertension": false, "lvef_percent": 60, "obesity": false, "prior_anthracycline": false, "prior_left_chest_or_mediastinal_rt": false, "proteinuria": false, "qtc_ms": 400, "sex": "female", "venous_thrombosis": false } ] }, "method": "POST", "type": "http" }, "output": { "example": { "count": 2, "items": [ { "age_years": 50, "cardiotoxicity_guide": "<2%", "citation": { "authors": "Lyon AR, Dent S, Stanway S, et al.", "doi": "10.1002/ejhf.1920", "id": "lyon-2020", "pmid": "32458582", "source": "Eur J Heart Fail. 2020;22(11):1945-1960", "title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society" }, "components": [ { "factor": "heart_failure_or_cardiomyopathy", "points": 0, "present": false, "tier": "very_high" }, { "factor": "arterial_vascular_disease", "points": 0, "present": false, "tier": "very_high" }, { "factor": "venous_thrombosis", "points": 0, "present": false, "tier": "high" }, { "factor": "lvef_lt_50", "points": 0, "present": false, "tier": "high" }, { "factor": "qtc_ge_480", "points": 0, "present": false, "tier": "high" }, { "factor": "age_ge_75", "points": 0, "present": false, "tier": "high" }, { "factor": "hypertension", "points": 0, "present": false, "tier": "high" }, { "factor": "prior_anthracycline", "points": 0, "present": false, "tier": "high" }, { "factor": "lvef_50_to_54", "points": 0, "present": false, "tier": "medium_2" }, { "factor": "borderline_qtc", "points": 0, "present": false, "tier": "medium_2" }, { "factor": "arrhythmia", "points": 0, "present": false, "tier": "medium_2" }, { "factor": "elevated_troponin", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "elevated_bnp", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "age_65_to_74", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "diabetes", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "hyperlipidemia", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "ckd", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "proteinuria", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "prior_left_chest_or_mediastinal_rt", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "current_or_significant_smoker", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "obesity", "points": 0, "present": false, "tier": "medium_1" } ], "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "hfa_icos_vegf", "formula_expression": "HFA-ICOS VEGF-inhibitor class (Lyon 2020): very_high if any very-high factor; else high if any high factor or medium_points>=5; else medium if medium_points 2-4; else low. medium_points = Medium 2 + Medium 1 only. Very high: heart_failure_or_cardiomyopathy, arterial_vascular_disease (IHD, PCI, CABG, stable angina, TIA, stroke, or PVD). High: venous_thrombosis, lvef_percent<50, qtc_ms>=480, age_years>=75, hypertension, prior_anthracycline. Medium 2: lvef 50-54, male 450<=qtc<480, female 460<=qtc<480, arrhythmia (AF/flutter/VT/VF). Medium 1: elevated_troponin, elevated_bnp, age 65-74, diabetes, hyperlipidemia, ckd, proteinuria, prior_left_chest_or_mediastinal_rt, current_or_significant_smoker, obesity. Age exclusive (>=75 High; 65-74 Medium 1; <65 none). LVEF exclusive (<50 High; 50-54 Medium 2; >=55 none). QTc exclusive (>=480 High; else sex-specific Medium 2). cardiotoxicity_guide low <2%, medium 2-9%, high 10-19%, very_high >=20%", "high_factor": false, "lvef_percent": 60, "medium_points": 0, "qtc_ms": 400, "risk_level": "low", "sex": "female", "very_high_factor": false }, { "age_years": 50, "cardiotoxicity_guide": "<2%", "citation": { "authors": "Lyon AR, Dent S, Stanway S, et al.", "doi": "10.1002/ejhf.1920", "id": "lyon-2020", "pmid": "32458582", "source": "Eur J Heart Fail. 2020;22(11):1945-1960", "title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society" }, "components": [ { "factor": "heart_failure_or_cardiomyopathy", "points": 0, "present": false, "tier": "very_high" }, { "factor": "arterial_vascular_disease", "points": 0, "present": false, "tier": "very_high" }, { "factor": "venous_thrombosis", "points": 0, "present": false, "tier": "high" }, { "factor": "lvef_lt_50", "points": 0, "present": false, "tier": "high" }, { "factor": "qtc_ge_480", "points": 0, "present": false, "tier": "high" }, { "factor": "age_ge_75", "points": 0, "present": false, "tier": "high" }, { "factor": "hypertension", "points": 0, "present": false, "tier": "high" }, { "factor": "prior_anthracycline", "points": 0, "present": false, "tier": "high" }, { "factor": "lvef_50_to_54", "points": 0, "present": false, "tier": "medium_2" }, { "factor": "borderline_qtc", "points": 0, "present": false, "tier": "medium_2" }, { "factor": "arrhythmia", "points": 0, "present": false, "tier": "medium_2" }, { "factor": "elevated_troponin", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "elevated_bnp", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "age_65_to_74", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "diabetes", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "hyperlipidemia", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "ckd", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "proteinuria", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "prior_left_chest_or_mediastinal_rt", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "current_or_significant_smoker", "points": 0, "present": false, "tier": "medium_1" }, { "factor": "obesity", "points": 0, "present": false, "tier": "medium_1" } ], "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "hfa_icos_vegf", "formula_expression": "HFA-ICOS VEGF-inhibitor class (Lyon 2020): very_high if any very-high factor; else high if any high factor or medium_points>=5; else medium if medium_points 2-4; else low. medium_points = Medium 2 + Medium 1 only. Very high: heart_failure_or_cardiomyopathy, arterial_vascular_disease (IHD, PCI, CABG, stable angina, TIA, stroke, or PVD). High: venous_thrombosis, lvef_percent<50, qtc_ms>=480, age_years>=75, hypertension, prior_anthracycline. Medium 2: lvef 50-54, male 450<=qtc<480, female 460<=qtc<480, arrhythmia (AF/flutter/VT/VF). Medium 1: elevated_troponin, elevated_bnp, age 65-74, diabetes, hyperlipidemia, ckd, proteinuria, prior_left_chest_or_mediastinal_rt, current_or_significant_smoker, obesity. Age exclusive (>=75 High; 65-74 Medium 1; <65 none). LVEF exclusive (<50 High; 50-54 Medium 2; >=55 none). QTc exclusive (>=480 High; else sex-specific Medium 2). cardiotoxicity_guide low <2%, medium 2-9%, high 10-19%, very_high >=20%", "high_factor": false, "lvef_percent": 60, "medium_points": 0, "qtc_ms": 400, "risk_level": "low", "sex": "female", "very_high_factor": false } ], "path": "/api/calc/hfa_icos_vegf" }, "type": "json" } }, "schema": { "$schema": "https://json-schema.org/draft/2020-12/schema", "properties": { "input": { "additionalProperties": false, "properties": { "body": { "additionalProperties": false, "properties": { "items": { "items": { "properties": { "age_years": { "description": "Integer age in years (18-100) as assigned by the caller. Lyon 2020 VEGF-inhibitor table: >=75 High; 65-74 Medium 1; <65 no age points. Bands are exclusive. magent does not read an identity document.", "type": "integer" }, "arrhythmia": { "description": "Arrhythmia (atrial fibrillation, atrial flutter, ventricular tachycardia, or ventricular fibrillation) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 2). true or false.", "type": "boolean" }, "arterial_vascular_disease": { "description": "Arterial vascular disease: IHD, PCI, CABG, stable angina, TIA, stroke, or PVD as one caller bool (Lyon 2020 VEGF-inhibitor table, very high). true or false. magent does not diagnose vascular disease.", "type": "boolean" }, "ckd": { "description": "Chronic kidney disease (eGFR <60 mL/min/1.73 m2) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not compute eGFR.", "type": "boolean" }, "current_or_significant_smoker": { "description": "Current smoker or significant smoking history as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.", "type": "boolean" }, "diabetes": { "description": "Diabetes mellitus (glycated haemoglobin >7.0% or >53 mmol/mol, or on treatment) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.", "type": "boolean" }, "elevated_bnp": { "description": "Elevated baseline BNP or NT-proBNP above the local laboratory upper limit of normal as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not assay BNP.", "type": "boolean" }, "elevated_troponin": { "description": "Elevated baseline troponin above the local laboratory upper limit of normal as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not assay troponin.", "type": "boolean" }, "heart_failure_or_cardiomyopathy": { "description": "Heart failure or cardiomyopathy (Lyon 2020 VEGF-inhibitor table, very high). Caller-assigned. true or false.", "type": "boolean" }, "hyperlipidemia": { "description": "Hyperlipidemia (non-HDL cholesterol >3.8 mmol/L or >145 mg/dL) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not convert lipid units.", "type": "boolean" }, "hypertension": { "description": "Hypertension (SBP >140 mmHg or DBP >90 mmHg, or on treatment) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, High). true or false. magent does not read a blood-pressure cuff.", "type": "boolean" }, "lvef_percent": { "description": "Baseline left-ventricular ejection fraction, integer percent 10-80, as assigned by the caller. <50 High; 50-54 Medium 2; >=55 no LVEF points. magent does not read an echocardiogram.", "type": "integer" }, "obesity": { "description": "Obesity (BMI >30 kg/m2) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not compute BMI.", "type": "boolean" }, "prior_anthracycline": { "description": "Prior anthracycline exposure as assigned by the caller (Lyon 2020 VEGF-inhibitor table, High). true or false.", "type": "boolean" }, "prior_left_chest_or_mediastinal_rt": { "description": "Prior radiotherapy to the left chest or mediastinum as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.", "type": "boolean" }, "proteinuria": { "description": "Proteinuria as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.", "type": "boolean" }, "qtc_ms": { "description": "Baseline QTc in milliseconds, integer 300-700, as assigned by the caller. >=480 High; men 450-479 Medium 2; women 460-479 Medium 2. magent does not measure QTc.", "type": "integer" }, "sex": { "description": "male or female as assigned by the caller. Used only for the sex-specific borderline QTc Medium 2 band (men 450-479 ms; women 460-479 ms).", "type": "string" }, "venous_thrombosis": { "description": "Venous thrombosis (DVT or PE) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, High). true or false.", "type": "boolean" } }, "required": [ "age_years", "sex", "lvef_percent", "qtc_ms", "heart_failure_or_cardiomyopathy", "arterial_vascular_disease", "venous_thrombosis", "hypertension", "prior_anthracycline", "arrhythmia", "elevated_troponin", "elevated_bnp", "diabetes", "hyperlipidemia", "ckd", "proteinuria", "prior_left_chest_or_mediastinal_rt", "current_or_significant_smoker", "obesity" ], "type": "object" }, "maxItems": 25, "minItems": 1, "type": "array" } }, "required": [ "items" ], "type": "object" }, "headers": { "additionalProperties": { "type": "string" }, "type": "object" }, "method": { "const": "POST", "type": "string" }, "type": { "const": "http", "type": "string" } }, "required": [ "type", "method" ], "type": "object" }, "output": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" } }, "required": [ "input" ], "type": "object" } } } }, "liveness": { "reliability": null }, "verified": false, "featured": false, "provider": { "host": "api.magentlab.com", "manifest_name": "api.magentlab.com", "source": "cdp-mirror", "source_manifest_url": "https://api.cdp.coinbase.com/platform/v2/x402/discovery/resources", "submitted_at": "2026-10-14T01:15:01.050Z" }, "exampleResponse": { "example": {}, "type": "string" } }